Thus, although there is a modest increase in sensitivity to cisplatin, the change may not be robust enough to suggest that SLC39A8 overexpression alone is a key determinant of cisplatin response in duodenal carcinoma cells. This evidence concerns the gene SLC39A8 and carcinoma of duodenum.